On Friday, Clinical Chemistry launched a new podcast format, the Clinician's Perspective. The first interview is with Dr. Allan Jaffe, the Laboratory Division Chair at the Mayo Clinic in Rochester, MN.
Click here to listen to the podcast.
Dr. Jaffe expressed some interesting thoughts regarding the adaptation of high-sensitivity assasys. Do you believe assays of this type will be approved by the FDA and adopted in labs throughout the US? Why or why not? Leave your answers in the comments.